Po Chung Chan

Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Caroline Even, Hung‐Ming Wang, Shau-Hsuan Li et al. · Clinical Cancer Research · 2021 · 58 citations · Full text

Medicine, Oncology, Pharmacology +17

The use of ketamine in the management of refractory cancer pain in a palliative care unit

Ka Wai Cheung, Po Chung Chan, Sing Hung Lo · Annals of Palliative Medicine · 2019 · 28 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Abstract CT150: Phase II study of spartalizumab (PDR001) vs chemotherapy (CT) in patients with recurrent/metastatic nasopharyngeal cancer (NPC)

Wan‐Teck Lim, Hung‐Ming Wang, Shau-Hsuan Li et al. · Cancer Research · 2019 · 16 citations

Medicine, Oncology, Pharmacotherapy +17

Patterns and infection outcomes of bacterial colonization in patients with indwelling abdominal drains for malignant ascites

Po Chung Chan, Ka Wai Cheung, Chun Hung Chan et al. · Annals of Palliative Medicine · 2020 · 13 citations · Full text

Medicine, Oncology, Surgery +15